Press Release

• Phyrago™ (dasatinib)
• Inluriyo™ (imlunestrant)
• Wayrilz™ (rilzabrutinib)
• HERNEXEOS^® (zongertinib)
• Modeyso^™ (dordaviprone)
• LYNOZYFIC^™ (linvoseltamab-gcpt)
• Augtyro^™ (repotrectinib)
• QINLOCK^® (ripretinib)
• ROMVIMZA^™ (vimseltinib)
• IBTROZI^™ (taletrectinib)